DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

NCT00596492 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

200

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to reasons unrelated to safety

Conditions

Mature Cataracts

Interventions

DRUG: DYME
DRUG: DYME

Sponsor

Aqumen Biopharmaceuticals, N.A.